Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A major collaborative study, in which DPAG’s Dr James Grist plays a key role, involving teams in the universities of Oxford, Sheffield, Cardiff and Manchester, has identified abnormalities in the lungs of Long Covid patients who are experiencing breathlessness. Researchers are using a novel xenon gas scanning method to locate damaged areas that cannot be detected by routine scans.

Increased brighter areas of gas activity can be seen on the healthy scan, whereas there are more 'dark' areas suggesting impaired gas activity on the patient scan. © University of Oxford

The EXPLAIN study has used hyperpolarised xenon MRI scans to uncover evidence of lung damage in a small group of people who were not hospitalised with Covid-19 yet continue to experience breathlessness long after initial infection. These abnormalities had previously not shown up on standard Computed Tomography (CT) scans. 

The work builds on an earlier study that used the same cutting-edge method of imaging to find persistent lung abnormalities in patients who had been admitted to hospital with Covid-19 several months after they were discharged.

Hyperpolarised xenon MRI is a safe scanning test that requires the patient to lie in the MRI scanner and breathe in one litre of the inert gas xenon that has been hyperpolarised so that it can be seen using MRI. As xenon behaves in a very similar way to oxygen, radiologists can observe how the gas moves from the lungs into the blood stream. The scan takes just a few minutes and, as it does not require radiation exposure, it can be repeated over time to see changes to the lungs.

These initial results show that there is “significantly impaired gas transfer” from the lungs to the bloodstream in these long COVID patients when other tests are normal.

DPAG Postdoctoral Research Scientist Dr James Grist, who has been running the scans and image analysis, said: “It’s real breakthrough that we can detect abnormalities in gas handling in the lungs of people that have never been hospitalised with COVID, yet now suffer from long COVID, in particular breathlessness. We cannot seem to find anything wrong on their normal CT scans, and yet here we can clearly see that there is something not right with our imaging technique. This is particularly useful because it may start to shed some light on why some people experience the symptom of breathlessness long after COVID, and will allow us quantitatively measure the effect of any therapies used to try and reverse this.”

Long Covid refers to a host of symptoms that continue for many weeks after a coronavirus infection and cannot be explained by another cause. More than a million people in the UK continue to experience symptoms months after having COVID-19, with breathlessness one of the most commonly reported symptoms.

A larger, more detailed study is under way to confirm the results. The full EXPLAIN study, supported by the NIHR Oxford Biomedical Research Centre (BRC), will recruit around 400 participants: 200 long COVID patients with breathlessness, along with 50 patients who have had COVID-19 but now have no symptoms at all; 50 patients who have no breathlessness, but do have other long COVID symptoms, such as ‘brain fog’; and 50 people who have never had long COVID who will act as controls for comparison. It is one of 19 studies that have received nearly £40 million investment from the National Institute for Health Research (NIHR) to improve understanding of long COVID, from diagnosis and treatment through to rehabilitation and recovery.

More information about the study and can be found on the NIHR Oxford BRC website.

The story has been covered by the BBCSky News, The Guardian, and many more publications and outlets.

Similar stories

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

Inaugural winners of the DPAG Prize for Public Engagement with Research announced

Congratulations are in order for the winners Katherine Brimblecombe and Anna Kordala, and also to Jéssica Luiz and Andia Redpath who were highly commended for their outreach and public engagement work.

New BBSRC grant to further our insights into how the cortex controls sleep

Professor of Sleep Physiology Vladyslav Vyazovskiy and Professor of Developmental Neuroscience Zoltán Molnár have been awarded a Project Grant from the Biotechnology and Biological Sciences Research Council (BBSRC) for “Brain mechanisms of sleep: top-down or bottom-up?”

Raised intracellular chloride levels underlie the effects of tiredness in cortex

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.